Salarius Pharmaceuticals (SLRX) and Decoy Therapeutics, a privately held firm, disclosed Monday a definitive agreement under which Decoy will merge with a wholly-owned subsidiary of Salarius.
Shares of Salarius soared about 142% as intraday trading volume catapulted to roughly 109 million from a daily average of more than 352,000.
Johnson & Johnson (JNJ) said Monday it agreed to acquire Intra-Cellular Therapies (ITCI) for about $14.6 billion in cash to strengthen its neuroscience portfolio.
Shares of Intra-Cellular advanced 34% as intraday trading volume soared to more than 28.7 million from a daily average of over 622,000.
CPI Aerostructures (CVU) said Raytheon Technologies (RTX) authorized CPI to begin manufacturing pod structures and air management system components. "The binding notification provides a maximum value of $33.4 million," CPI said.
Shares of CPI jumped 16%, with intraday trading volume at over 176,000 compared with a daily average of more than 42,000.
Price: 3.97, Change: +2.41, Percent Change: +154.42
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。